The USC scientist who aims to beat ALS, and the patients cheering him on
Justin Ichida gives his all to find a cure for Lou Gehrig’s disease because, for patients, the clock is ticking.
Why nerve cells die in ALS and some dementia cases
Scientists use study to focus their search on new therapies that can treat these devastating diseases.
USC researcher looks for a pattern in ALS cases
Kim Staats is drawn to the clinical relevance of research in Justin Ichida’s lab, which explores ALS mechanisms.
USC scientists in different labs take on a neurodegenerative disease
Haoze (Vincent) Yu and Kate Galloway receive grants for a collaborative project that demonstrates their creativity and independence.
USC Stem Cell scientist ramps up ALS research
Justin Ichida teams with pharmaceutical company and startup to battle Lou Gehrig’s disease.
USC scientist screens potential therapies for Lou Gehrig’s disease
Justin Ichida tests drug-like compounds on motor neurons formed by reprogramming skin cells from ALS patients.
USC faculty receive early career support
Baxter Foundation grants will allow investigators to perform the innovative research that may eventually benefit patients.
Keck School’s experimental drug for ALS shows promise
Keck School neuroscientists have unlocked a piece of the puzzle in the fight against the debilitating neurological disorder that robs people of their motor skills.